Cargando…

Phospholipase A2 enzyme from the venom of Egyptian honey bee Apis mellifera lamarckii with anti-platelet aggregation and anti-coagulation activities

BACKGROUND: Honey bee venom contains various enzymes with wide medical and pharmaceutical applications. RESULTS: The phospholipase A2 (PLA2) has been apparently purified from the venom of Egyptian honey bee (Apis mellifera lamarckii) 8.9-fold to a very high specific activity of 6033 U/mg protein usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Darwish, Doaa A., Masoud, Hassan M. M., Abdel-Monsef, Mohamed M., Helmy, Mohamed S., Zidan, Hind A., Ibrahim, Mahmoud A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809086/
https://www.ncbi.nlm.nih.gov/pubmed/33443641
http://dx.doi.org/10.1186/s43141-020-00112-z
Descripción
Sumario:BACKGROUND: Honey bee venom contains various enzymes with wide medical and pharmaceutical applications. RESULTS: The phospholipase A2 (PLA2) has been apparently purified from the venom of Egyptian honey bee (Apis mellifera lamarckii) 8.9-fold to a very high specific activity of 6033 U/mg protein using DEAE–cellulose and Sephacryl S-300 columns. The purified bee venom PLA2 is monomeric 16 kDa protein and has isoelectric point (pI) of 5.9. The optimal activity of bee venom PLA2 was attained at pH 8 and 45 °C. Cu(2+)(,) Ni(2+), Fe(2+)(,) Ca(2+), and Co(2+) exhibited a complete activating effect on it, while Zn(2+), Mn(2+), NaN(3), PMSF, N-Methylmaleimide, and EDTA have inhibitory effect. CONCLUSIONS: The purified bee venom PLA2 exhibited anti-platelet aggregation and anti-coagulation activities which makes it promising agent for developing novel anti-clot formation drugs in future.